Concomitant Gastric Acid Suppressants on the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis

<div>Forest plots for the subgroup analyses of the association between concomitant AS use and PFS in NSCLC patients taking TKIs. (a) Subgroup analysis according to the country of the study and (b) subgroup analysis according to TKIs used.</div>

International Journal of Clinical Practice

fig3

Figure 3

Figure 3: Concomitant Gastric Acid Suppressants on the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis 

Figure 3 | Concomitant Gastric Acid Suppressants on the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis 